FIELD: medicine.
SUBSTANCE: oral introduction of monoacetyldiacylglycerin derivatives detains development of hamster's induced cancer by activation of lymphocytes, monocytes and dendritic cells, as well as apoptosis induction of cancer cells owing to intensified cytotoxicity of immune cells in relation to cancer cells. Besides, induction of septic shock at mice is accompanied with shown 100% survival rate even in 120 hours, reached by immunity control and suppressing apoptosis effect. Monoacetyldiacylglycerin derivatives according to this invention can be effectively applied as agent for sepsis and cancer treatment and as healthy food preventing cancer or autoimmune diseases.
EFFECT: discovers application of monoacetyldiacylglycerin derivatives extracted from antler as agent suppressing cell abnormality resulted from autoresponse.
11 cl, 16 dwg, 11 ex, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR DETECTION OF CANCER BLOOD DISEASES OR METASTASIS OF CANCER CONTAINING ACTIVE INGREDIENT MONOACETHYL DIGLYCERIDE COMPOUND | 2014 |
|
RU2632098C2 |
METHODS OF TREATING LEUKOPENIA AND THROMBOCYTOPENIA | 2015 |
|
RU2702122C2 |
COMPOSITIONS CONTAINING MONOACETYLDIACYLGLYCERIDE AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS | 2014 |
|
RU2646823C2 |
COMPOSITION FOR PREVENTING OR TREATING MALIGNANT TUMOUR, COMPRISING AGENT DESTROYING VESSELS, AND IMMUNE CONTROL POINT INHIBITOR | 2018 |
|
RU2738369C1 |
COMPOSITION FOR PREVENTION OR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASES CONTAINING MONOACETHYLDIGLYCEROL COMPOUNDS AS ACTIVE INGREDIENT | 2014 |
|
RU2642631C2 |
COMPOSITION FOR ATOPIC ECZEMA PREVENTION OR TREATMENT CONTAINING MONOACETYLDIACYL GLYCERINE COMPOUND AS ACTIVE INGREDIENT | 2014 |
|
RU2640503C2 |
COMPOSITION FOR ASTHMA PREVENTION OR TREATMENT CONTAINING MONOACETHYLDIACYL GLYCERINE COMPOUND AS ACTIVE INGREDIENT | 2014 |
|
RU2636615C2 |
VACCINE BASED ON B-CELLS, LOADED WITH LIGANDS OF T-CELLS-NATURAL KILLERS AND ANTIGEN | 2006 |
|
RU2420311C2 |
RECOMBINANT ADENOVIRUS CONTAINING TRANS-SPLICING MEDIATING RIBOZYME, AND ANTI-CANCER THERAPEUTIC GENE, AND USING IT | 2012 |
|
RU2575620C2 |
MODULAR PARTICLES FOR IMMUNOTHERAPY | 2014 |
|
RU2672055C2 |
Authors
Dates
2008-12-20—Published
2005-04-22—Filed